Filtra per Last updated date SelectDopoPrimaFrom - To Date Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Esito (3827) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Committee for veterinary medicinal products: 53rd meeting 9 Marzo 2000Press releaseVeterinary Public Statement on the risk of drug interactions with Hypericum perforatum (St John's Wort) and antiretroviral medicinal products 28 Febbraio 2000News Committee for Proprietary Medicinal Products (CPMP) 57th plenary meeting 21 Febbraio 2000Press release Public statement on Insuman Infusat 100-IU/ml solution for injection in cartridges of 3.15 ml (insulin human) - Risk of leakage during use 14 Febbraio 2000News Committee for veterinary medicinal products: 52nd meeting 10 Febbraio 2000Press releaseVeterinary Public Statement on Ziagen (Abacavir) - Important safety Information on Hypersensitivity Reactions and Respiratory Symptoms 24 Gennaio 2000News Committee for Proprietary Medicinal Products (CPMP) 56th plenary meeting 24 Gennaio 2000Press release 3rd meeting of the Committee for Orphan Medicinal Products 19 Gennaio 2000Press releaseHumanRare diseases Committee for veterinary medicinal products: 51st meeting 13 Gennaio 2000Press releaseVeterinary Public Statement on Rapilysin (Reteplase) - Incompatibility with Heparin and Precipitation following the Reconstitution - Important New Instructions for Use 23 Dicembre 1999News 1 … 365 366 367 368 369 Page 369 of 383 370 371 372 373 … 383
Public Statement on the risk of drug interactions with Hypericum perforatum (St John's Wort) and antiretroviral medicinal products 28 Febbraio 2000News
Committee for Proprietary Medicinal Products (CPMP) 57th plenary meeting 21 Febbraio 2000Press release
Public statement on Insuman Infusat 100-IU/ml solution for injection in cartridges of 3.15 ml (insulin human) - Risk of leakage during use 14 Febbraio 2000News
Public Statement on Ziagen (Abacavir) - Important safety Information on Hypersensitivity Reactions and Respiratory Symptoms 24 Gennaio 2000News
Committee for Proprietary Medicinal Products (CPMP) 56th plenary meeting 24 Gennaio 2000Press release
3rd meeting of the Committee for Orphan Medicinal Products 19 Gennaio 2000Press releaseHumanRare diseases
Public Statement on Rapilysin (Reteplase) - Incompatibility with Heparin and Precipitation following the Reconstitution - Important New Instructions for Use 23 Dicembre 1999News
